ArticleAnnals of translational medicine2022

A single-arm, prospective study of apatinib mesylate plus pemetrexed in patients of advanced non-squamous non-small cell lung cancer after failure of previous chemotherapy.

Shuang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.